Xinglong Zhong | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Xinglong Zhong | Cardiovascular Pharmacology | Best Researcher Award

Prof. Xinglong Zhong, Department of Cardiology, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers’ Hospital, China

Prof. Xinglong Zhong is a dedicated cardiologist specializing in the diagnosis and treatment of cardiovascular diseases, with expertise in independent coronary angiography. 🏥 His clinical practice is complemented by a strong research background, focusing on vascular aging, myocardial fibrosis, and vascular calcification. 🔬 He has co-authored multiple peer-reviewed papers in prestigious SCI-indexed journals and has accumulated 244 citations with a top paper cited 127 times. 📊 His innovative work bridges interventional cardiology and molecular research, positioning him as a rising figure in cardiovascular science and precision medicine. 🌐❤️ His efforts continue to advance heart health through scientific discovery.

Publication Profile  

Orcid

Education

Prof. Xinglong Zhong 🫀 is a skilled cardiologist specializing in the diagnosis and treatment of cardiovascular diseases, with particular expertise in independent coronary angiography. 🏥 His clinical proficiency is matched by a strong foundation in research, enabling him to bridge hands-on patient care with scientific innovation. 🔬 He has co-authored several peer-reviewed articles published in SCI-indexed journals, contributing valuable insights into vascular health and cardiology. 📚 His work exemplifies a harmonious integration of advanced interventional cardiology and active academic engagement, making him a vital contributor to both clinical excellence and medical research.

Professional Memberships

Prof. Xinglong Zhong 🩺 is currently not affiliated with any professional memberships or academic societies. While he does not hold formal memberships, his impactful research contributions and clinical expertise in cardiology speak volumes about his dedication to the field. 📚🧬 His work continues to gain recognition through high-quality publications and citation metrics, reflecting his independent commitment to advancing cardiovascular science. 🚀🔬 Despite the absence of organizational affiliations, Prof. Zhong remains a respected figure in both research and clinical communities, demonstrating that consistent innovation and scholarly excellence can shine through individual initiative and professional dedication.

Research Focus

Prof. Xinglong Zhong’s research focus lies in cardiovascular pathophysiology, with a special emphasis on vascular calcification, myocardial fibrosis, and molecular mechanisms of aging in chronic kidney disease. 🔍 His work explores the impact of gut-derived metabolites like trimethylamine-N-oxide (TMAO), inflammatory signaling pathways (NF-κB, NLRP3), and therapeutic agents such as puerarin and dihydromyricetin. 💊 He also investigates cutting-edge strategies like supramolecular hydrogels for cellular senescence and novel concepts like ion therapy in myocardial infarction. 🧪 His multidisciplinary approach bridges molecular cardiology and regenerative therapy, advancing precision treatment in heart and vascular diseases.

Publication Top Notes

  • Trimethylamine-N-oxide promotes vascular aging via inhibiting GATA4 degradation in chronic kidney disease rats
  • Enhanced fibrotic potential of COL1A1hiNR4A1low fibroblasts in ischemic heart revealed by transcriptional dynamics heterogeneity analysis at both bulk and single-cell levels
  • Lactobacillus rhamnosus GG aggravates vascular calcification in chronic kidney disease: A potential role for extracellular vesicles
  • Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling
  • Puerarin Alleviates Lipopolysaccharide-Induced Myocardial Fibrosis by Inhibiting PARP-1 to Prevent HMGB1-Mediated TLR4-NF-κB Signaling Pathway
  • Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals
  • β-Galactosidase instructed supramolecular hydrogelation for selective identification and removal of senescent cells

  • CDC42 promotes vascular calcification in chronic kidney disease

Dan Yan | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Dan Yan | Pharmacology | Best Researcher Award

Prof. Dan Yan, Beijing Friendship Hospital, Capital Medical University, China China

Prof. Dan Yan is the Director of the Pharmacy Department and Vice Director of the Drug Clinical Trial Institution at Beijing Friendship Hospital, Capital Medical University. A leading expert in intelligent molecular diagnosis and combination therapies for chronic metabolic diseases, he has authored numerous high-impact publications and led national research projects. With a Ph.D. from Chengdu University of Traditional Chinese Medicine and postdoctoral training in cell biology, Prof. Yan also serves on key national academic committees. He work bridges traditional Chinese medicine with modern pharmacology to advance precision healthcare.

Publication Profile

Scopus

Education

Prof. Dan Yan 🎓 has dedicated he academic journey to the field of Traditional Chinese Medicine. He earned he Ph.D. (2004–2007), M.S. (2001–2004), and B.S. (1994–1998) degrees—all from the esteemed Chengdu University of Traditional Chinese Medicine 🏛️. He consistent pursuit of knowledge over the years reflects a deep passion for advancing holistic health and medical science rooted in ancient wisdom 🌿. With a strong foundation in both theoretical and practical aspects of Traditional Chinese Medicine, Prof. Yan continues to contribute significantly to research, education, and innovation in this timeless and evolving discipline 📚🔬.

Experience

Prof. Dan Yan 🌟 has actively served on numerous prestigious academic committees, showcasing he leadership in Traditional Chinese Medicine. Since 2023, he has been recognized as a National High-level Leading Talent 🇨🇳, Director of a Key Discipline under the National Administration of TCM 🏛️, and a recipient of the Chinese Government Special Allowance 🏅. He is also a member of the China National Pharmacopoeia Committee (2022–2027) 📘 and holds leadership roles in institutes focused on clinical pharmacy, precision medicine, and rational drug use 💊📊. He extensive contributions highlight he dedication to advancing science, policy, and international collaboration in healthcare 🌐🧬.

Research Focus

Prof. Dan Yan is a leading researcher in metabolic diseases, particularly focusing on type 2 diabetes, insulin resistance, and gut microbiota 🧫. He research integrates microbiome science, metabolomics, and traditional Chinese medicine🌿 to develop novel therapeutic strategies. He investigates microbial metabolites (e.g., succinate, L-citrulline) and their roles in modulating intestinal immunity🦠 and enhancing drug responses like metformin efficacy💊. He studies also include chemodynamic therapy, biomarker discovery, and machine learning-based screening in diabetes diagnostics 🤖. Prof. Yan’s contributions are reshaping how we understand and manage chronic metabolic disorders on a molecular and systemic level.

Publication Top Notes

Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis

Function, mechanism of action, metabolism, and commercial application of Lonicera japonica: a review

Coupling Probiotics with CaO2 Nanoparticle-Loaded CoFeCe-LDH Nanosheets to Remodel the Tumor Microenvironment for Precise Chemodynamic Therapy

Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity

Circulating metabolites difference in type 2 diabetes patients from regions: a cross-sectional study

Detecting key genes relative expression orderings as biomarkers for machine learning-based intelligent screening and analysis of type 2 diabetes mellitus

Advances in in vitro assessment models and screening methods for blood glucose-lowering medications

Discovery of the targets and lead compounds of traditional chinese medicine based on the molecular trajectory of diabetes evolution

3D spheroid HepaRG and fluorescent biphasic tracer for CYP3A4-mediated antibiotic interaction monitoring in sepsis

Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin

Ewa Obuchowicz | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Ewa Obuchowicz | Pharmacology | Best Researcher Award

Prof. Ewa Obuchowicz, Medical University of Silesia, Poland

Prof. Ewa Obuchowicz is the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia. She earned her M.Sc. in 1979, Ph.D. in 1985, became an Associate Professor in 2001, and a Professor in 2011. Her research focuses on psychotropic drugs, neuropeptides, cytokines, and glioblastoma therapy 🧠🔬. She has authored 89 scientific papers, with over 2,000 citations and an h-index of 20. A recipient of multiple awards 🏆, she is an esteemed member of the Polish Pharmacological Society.

Publication Profile

Scopus

Education

Prof. Ewa Obuchowicz 🎓 is a distinguished expert in pharmacology, with an impressive academic journey spanning decades. She earned her M.Sc. in 1979, followed by a Ph.D. in 1985, and attained full professorship in 2011. As the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia 🏥, she exemplifies leadership and dedication to advancing medical research. Her extensive contributions and unwavering commitment to the field make her a strong candidate for the Best Researcher Award 🏆, highlighting her impact on academia and scientific progress.

Experience 

Prof. Ewa Obuchowicz 🔬 is a renowned researcher specializing in psychotropic drug mechanisms, neuropeptides, cytokines, and glial cell protein expression. Her work delves into the complex interplay between stress, immunostimulation, and neurotrophic factors 🧠, shedding light on crucial neurological processes. Additionally, she has explored the role of the endocannabinoid system 🌿 and contributed to developing innovative adjuvant therapies for glioblastoma 🎗️. Her groundbreaking research plays a vital role in advancing medical and pharmacological sciences, solidifying her reputation as a distinguished scientist in the field. Her dedication continues to shape the future of neuropharmacology and therapeutic innovation.

Scientific Achievements

Prof. Ewa Obuchowicz 📚 has made a remarkable impact on the scientific community with 89 full-length publications, 71 of which have been cited over 2,000 times. With an h-index of 20 (Scopus) 📊, her research has gained widespread recognition. Notably, five of her papers have been cited over 100 times, highlighting their profound influence. Beyond research articles, she has contributed to authoritative pharmacology handbooks 📖, further solidifying her scholarly excellence. Her outstanding publication record and significant contributions to the field make her a deserving candidate for the award 🏆, reflecting her dedication to advancing pharmacological sciences.

Professional Memberships

Prof. Ewa Obuchowicz 🤝 is an active member of the Polish Pharmacological Society, where she contributes to professional discussions and advancements in pharmacology. Through her engagement with research organizations 🏛️, she fosters collaboration and drives progressive scientific discoveries. Her dedication to the field extends beyond her own research, as she actively participates in shaping the future of pharmacology through knowledge exchange and professional networking. By staying at the forefront of scientific discourse, she continuously enhances the impact of her work, reinforcing her role as a key contributor to the advancement of medical and pharmacological sciences.

Awards

Prof. Ewa Obuchowicz 🏅 has received prestigious recognition for her outstanding contributions to medical and pharmacological research. She has been honored with two Scientific Awards from the Minister of Health and Social Welfare 🏆 and thirteen Scientific Awards from the Rector of the Medical University of Silesia in Katowice 🎖️. These accolades reflect her dedication, innovation, and impact in the field. Her groundbreaking research and scholarly achievements continue to shape the future of pharmacology, further solidifying her candidacy for the Best Researcher Award 🏅 and reinforcing her status as a leading figure in medical science.

Research Focus

Professor Ewa Obuchowicz is a distinguished neuroscientist specializing in psychopharmacology 🧠💊, with a research focus on depression, stress, and the endocannabinoid system. Her work explores the mechanisms of antidepressants, particularly escitalopram, and their effects on neurotransmission, gene expression, and behavioral responses. She has contributed significantly to preclinical models of stress and mood disorders, investigating the role of neuropeptides, oxytocin, and the hypothalamus-pituitary-gonadal (HPG) axis 🔬📊. Additionally, her research extends to neuro-oncology, examining glioblastoma treatments. Through her studies, she aims to advance mental health therapeutics and improve understanding of stress-induced disorders.

Publication Top Notes

Escitalopram reverses anxiety-like and despair behavior and affects endocannabinoid-related genes expression in the brain of adolescent male rats subjected to early life stress

Acute Stress Affects the Relaxin/Insulin-Like Family Peptide Receptor 3 mRNA Expression in Brain of Pubertal Male Wistar Rats

How depression and antidepressant drugs affect endocannabinoid system?—review of clinical and preclinical studies

A Dot-Blot Screening for Identifying the Temozolomide-Regulated Proteins as Potential Targets for Glioma Multi-OMICS Studies

Escitalopram alters the hypothalamic OX system but does not affect its up-regulation induced by early-life stress in adult rats.

Neuropeptides as regulators of the hypothalamus-pituitary-gonadal (HPG) axis activity and their putative roles in stress-induced fertility disorders

Glucose Influences the Response of Glioblastoma Cells to Temozolomide and Dexamethasone

May application of oxytocin be relevant in the therapy of perinatal mental disorders?

Soufiene Bettaibi | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Soufiene Bettaibi | Cardiovascular Pharmacology | Best Researcher Award

Assoc. Prof. Dr. Soufiene Bettaibi, International University of Rabat, UIR, Morocco

Assoc. Prof. Dr. Soufiene Bettaibi is a distinguished expert in Fluid Mechanics and Heat & Mass Transfer 🔥💧. He holds a Master’s and Ph.D. in these fields, earned through collaborations with the Faculty of Science of Tunis, CETHIL (INSA Lyon), and IAC-CNR (Rome) 🏛️. Currently, he serves as an Associate Professor at the Higher School of Energy Engineering, International University of Rabat (UIR), Morocco 🇲🇦. His research focuses on nanofluids, biomechanics, and energy systems ⚙️🧪, with numerous ISI-indexed publications 📚 and active participation in international conferences & projects 🌍🔍

Publication Profile

Google Scholar

Academic Background

Assoc. Prof. Dr. Soufiene Bettaibi 🎓 is a distinguished expert in Fluid Mechanics and Heat and Mass Transfer. He earned his Master’s and Ph.D. degrees through collaborative research with prestigious institutions, including the Faculty of Science of Tunis, CETHIL (INSA Lyon) 🇫🇷, and IAC-CNR (Rome) 🇮🇹. His strong academic foundation and extensive research contributions have positioned him as a key figure in advancing scientific knowledge in these specialized fields. Dr. Bettaibi’s expertise continues to drive innovation, shaping the future of fluid dynamics and thermal sciences with groundbreaking research and interdisciplinary collaborations. 🔬🔥

Research Impact

Assoc. Prof. Dr. Soufiene Bettaibi 🎓 is a dedicated researcher and educator at the Higher School of Energy Engineering, International University of Rabat (UIR) 🇲🇦. His expertise in Fluid Mechanics and Heat and Mass Transfer has led to groundbreaking research that enhances scientific understanding in these critical fields. Through his work, Dr. Bettaibi has made significant contributions to academia, fostering innovation and advancing knowledge in energy engineering. His research not only enriches the scientific community but also plays a crucial role in developing sustainable and efficient thermal systems for future applications. 🔬⚙️🔥

Conference Engagement

Assoc. Prof. Dr. Soufiene Bettaibi 📚 has made significant contributions to the scientific community through his numerous ISI-indexed publications, reflecting the depth and rigor of his research. In addition to his scholarly work, he actively engages in national and international conferences and workshops 🌍🎤, where he presents his findings and collaborates with experts worldwide. His participation in these events strengthens global scientific discourse, fosters innovation, and enhances interdisciplinary research in Fluid Mechanics and Heat and Mass Transfer. Dr. Bettaibi’s commitment to knowledge dissemination continues to inspire and drive advancements in his field. 🔬📖

Research Focus

Assoc. Prof. Dr. Soufiene Bettaibi focuses on computational fluid dynamics (CFD) 🌊, lattice Boltzmann method (LBM) 🧮, heat and mass transfer 🔥💨, and magnetohydrodynamics (MHD) 🧲. His research explores mixed convection flows in cavities 🏠, blood flow modeling in arteries 🩸, and multiphysics simulations 📊. He applies finite difference methods 📐 and mesoscopic modeling 🌀 to solve complex engineering and biomedical problems. His studies have significant applications in biomedical engineering 🏥, energy systems ⚡, and thermal management ❄️. Through his advanced numerical simulations, Dr. Bettaibi contributes to fluid dynamics innovation 🚀 and interdisciplinary scientific advancements 🔬.

Publication Top Notes

Hybrid LBM-MRT model coupled with finite difference method for double-diffusive mixed convection in rectangular enclosure with insulated moving lid

Hybrid lattice Boltzmann finite difference simulation of mixed convection flows in a lid-driven square cavity

Lattice Boltzmann simulation of mixed convection heat transfer in a driven cavity with non-uniform heating of the bottom wall

Magnetohydrodynamic blood flow study in stenotic coronary artery using lattice Boltzmann method

Numerical study of thermal diffusion and diffusion thermo effects in a differentially heated and salted driven cavity using MRT-lattice Boltzmann finite difference model

Numerical study of pulsatile thermal magnetohydrodynamic blood flow in an artery with aneurysm using lattice Boltzmann method (LBM)

MRT-lattice Boltzmann hybrid model for the double diffusive mixed convection with thermodiffusion effect

Double diffusive mixed convection with thermodiffusion effect in a driven cavity by lattice Boltzmann method

Double population lattice Boltzmann model for magneto-hydrodynamic blood flow in stenotic artery

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Assoc. Prof. Dr Mahshid Malakootian, Rajaie cardiovascular medical and research center, Iran

Born on March 21, 1981, in Tehran, Iran, Dr. Mahshid Malakootian is a distinguished molecular geneticist and Associate Professor at Rajaie Cardiovascular Medical & Research Institute, Tehran. A prolific researcher, she specializes in non-coding RNAs, cardiovascular genetics, and bioinformatics. She completed her Ph.D. in Molecular Genetics at Tarbiat Modares University and held postdoctoral fellowships at McGill University and Case Western Reserve University. Dr. Malakootian has published extensively and received numerous accolades, including Best Young Researcher awards. Fluent in English and Persian, she is a dedicated academic, head of the Cardiogenetic Research Center, and an editorial board member. 📚🧬🌍

Publication Profile

google scholar

Academic Excellence

Assoc. Prof. Dr. Mahshid Malakootian is a distinguished expert in molecular genetics and cardiogenetics, contributing significantly to the field. Since 2021, she has served as an Associate Professor at the Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran. 💡 From 2018, she has led the center as its Head, advancing groundbreaking research in cardiovascular genetics. 🧬 Previously, she was an Assistant Professor from 2015 to 2021 and has been an active board member of the Research Deputy since 2015, shaping impactful scientific initiatives. 📚 Her work continues to drive innovation in cardiovascular health. ❤️

Research Experience

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished molecular geneticist with extensive research experience. She pursued her post-doctorate in Experimental Medicine at McGill University, Canada (2016-2017), focusing on PCSK7 RNA regulators 🧬. Previously, she was a post-doctoral fellow at Tarbiat Modares University, Tehran (2014-2015), and a visiting research scholar at Case Western Reserve University, USA (2011-2012) 🔬. Dr. Malakootian earned her Ph.D. (2009-2014) and M.Sc. (2004-2007) in Molecular Genetics at Tarbiat Modares University, where she explored non-coding RNAs and tumorigenesis. Her academic journey began with a B.Sc. in Cellular and Molecular Sciences from the University of Tehran (1999-2003) 🧪.

Honors and Awards

Assoc. Prof. Dr. Mahshid Malakootian is an award-winning researcher recognized for her outstanding contributions in molecular genetics and stem cell technology. 🏆 She has earned accolades such as the “Best Young Researcher” award (2017, 2019) and the “Top Thesis Award” (2014). 🎖 Her pioneering research is supported by multiple grants, including studies on noncoding RNAs and cardiovascular biomarkers. She has discovered and sequenced numerous novel genetic variants, published in GenBank, and co-authored a U.S. patent for miR-her2-1, aiding breast and ovarian cancer diagnostics. 💡📚 A scholar of exceptional caliber, Dr. Malakootian remains a trailblazer in biomedical innovation. 🌟

Professional Societies

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished scientist and an active member of prestigious organizations, including the American Association for Cancer Research (AACR) 🌟, the Iranian Genetics Society (IGS) 🧬, and the Iranian Biotechnology Society 🌿. Her dedication to advancing research is reflected in her role as an editorial board member of the Environmental Health Engineering and Management Journal 📚. With her extensive expertise and contributions, she continues to shape the fields of cancer research, genetics, and biotechnology, fostering innovative solutions for global health challenges 🌍. Dr. Malakootian’s work exemplifies excellence and inspires the scientific community. ✨

Teaching Experience

Associate Professor Dr. Mahshid Malakootian is a distinguished expert in molecular genetics at Shahed University, where she also leads the Advanced Molecular Genetics Lab Course 🧬. Her dedication to education and research has inspired countless students and colleagues. Dr. Malakootian has honed her expertise as a research assistant in Dr. Mowla’s laboratory, contributing to cutting-edge discoveries in molecular genetics 🔬. With a passion for advancing knowledge, she has made significant strides in her field, combining academic excellence with hands-on laboratory experience. Her work continues to shape the future of genetic research and education, making her a respected figure in the scientific community.

Research Focus

Assoc. Prof. Dr. Mahshid Malakootian focuses on cutting-edge research in microRNAs, cardiovascular diseases, and non-coding RNAs in various biological and pathological contexts. Her work explores microRNA roles in cardiovascular development, post-transcriptional regulation, and cancer biology, particularly lung and esophageal tumors. Dr. Malakootian also investigates long non-coding RNAs (lncRNAs), circular RNAs, and their interplay in genetic regulation and disease pathways. Her studies on epigenetics and innovative therapeutic approaches significantly impact cardiovascular health and cancer treatment. 🧬🩺🫀

Publication Top Notes

MicroRNAs: roles in cardiovascular development and disease

Post-transcriptional regulation of PCSK9 by miR-191, miR-222, and miR-224

Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors

Ciprofloxacin removal from aqueous media by adsorption process: a systematic review and meta-analysis

Pathophysiology, Diagnosis, Treatment, and Genetics of Carpal Tunnel Syndrome: A Review

Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma

Overexpression of BMI1, a polycomb group repressor protein, in bladder tumors: a preliminary report

Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors

lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells